Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (23 ops.)
Latest filing published 09 Oct 2026 for Immunovant, Inc., €63k. Read the official filing
Filing timeline
BuySaleJay S. Stout
Insider track record
Disclosed buys
0
Disclosed sells
23
Signal history
Jay S. Stout: trading record in brief
All filings by Jay S. Stout on record concern Immunovant, Inc., in the capacity of senior executive. Over a trading history stretching from 17 April 2023 to 7 October 2026, the count stands at 27 filings.
The open-market record consists of 23 sales worth €1.3M, with no purchase. No amount is published for 2 filings, which the totals therefore leave out. Other entries cover 4 share grants. In 2026 alone, the filings show no purchases and 13 sales.
On 9 October 2026 came the latest disclosure, an open-market sale for €63k in Immunovant, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jay S. Stout
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations27 total
2,213 shares@ US$32.060.0011% mcap5.0% of flowCommon StockSEC:0001702969-26-000012:0
1,596 shares@ US$32.060.0008% mcap3.6% of flowCommon StockSEC:0001702969-26-000012:1
2,857 shares@ US$38.690.0016% mcap8.4% of flowCommon StockSEC:0001702969-26-000010:0
1,906 shares@ US$39.530.0011% mcap5.8% of flowCommon StockSEC:0001764013-26-000081:0
105 shares@ US$39.990.0001% mcap0.3% of flowCommon StockSEC:0001764013-26-000081:1
1,399 shares@ US$39.530.0008% mcap4.2% of flowCommon StockSEC:0001764013-26-000081:2
77 shares@ US$39.990.0000% mcap0.2% of flowCommon StockSEC:0001764013-26-000081:3
33,277 sharesCommon StockSEC:0001764013-26-000074:0
6,723 sharesCommon StockSEC:0001764013-26-000074:1
2,754 shares@ US$29.620.0009% mcap6.1% of flowCommon StockSEC:0001764013-26-000055:0
8,614 shares@ US$24.830.0023% mcap16.0% of flowCommon StockSEC:0001702969-26-000006:0
66,937 shares0Common StockSEC:0001764013-26-000038:0
1,977 shares@ US$26.030.0006% mcap3.8% of flowCommon StockSEC:0001702969-26-000002:0
1,148 shares@ US$26.510.0003% mcap2.3% of flowCommon StockSEC:0001764013-26-000002:0
2,520 shares@ US$19.030.0005% mcap3.6% of flowCommon StockSEC:0001764013-25-000143:0
1,585 shares@ US$16.300.0003% mcap1.9% of flowCommon StockSEC:0001764013-25-000138:0
2,805 shares@ US$18.150.0005% mcap3.8% of flowCommon StockSEC:0001764013-25-000115:0
1,519 shares@ US$17.240.0003% mcap1.9% of flowCommon StockSEC:0001764013-25-000108:0
1,925 shares@ US$14.792.2% of flowCommon StockSEC:0001764013-25-000083:0
5,004 shares@ US$12.995.2% of flowCommon StockSEC:0001764013-25-000069:0
76,181 shares0Common StockSEC:0001764013-25-000055:0
2,195 shares@ US$23.594.3% of flowCommon StockSEC:0001764013-25-000019:0
2,740 shares@ US$29.536.5% of flowCommon StockSEC:0001764013-24-000178:0
2,813 shares@ US$27.766.3% of flowCommon StockSEC:0001764013-24-000143:0
7,239 shares@ US$28.9017.0% of flowCommon StockSEC:0001764013-24-000087:0
25 of 27 declarations
